{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:24:03Z","timestamp":1783646643747,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,27]]},"DOI":"10.7759\/cureus.23548","type":"journal-article","created":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T22:45:21Z","timestamp":1648421121000},"source":"Crossref","is-referenced-by-count":7,"title":["Trend Analysis of Substance Use Disorder During Pregnancy"],"prefix":"10.7759","author":[{"given":"Memory","family":"Ndanga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saanie","family":"Sulley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abimbola  K","family":"Saka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2019.11.359","article-title":"Opioid use disorder in pregnancy","volume":"9","author":"Harter K","year":"2019","unstructured":"Harter K. Opioid use disorder in pregnancy. Ment Health Clin. 2019, 9:359-72. 10.9740\/mhc.2019.11.359","journal-title":"Ment Health Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-06182-0","article-title":"Opioid use disorder in pregnancy: leveraging provider perceptions to inform comprehensive treatment","volume":"21","author":"Titus-Glover D","year":"2021","unstructured":"Titus-Glover D, Shaya FT, Welsh C, Qato DM, Shah S, Gresssler LE, Vivrette R. Opioid use disorder in pregnancy: leveraging provider perceptions to inform comprehensive treatment. BMC Health Serv Res. 2021, 21:215. 10.1186\/s12913-021-06182-0","journal-title":"BMC Health Serv Res"},{"key":"ref3","article-title":"Opioid prescription claims among women of reproductive age \u2014 United States, 2008-2012","volume":"64","author":"Ailes EC","year":"2015","unstructured":"Ailes EC, Dawson AL, Lind JN, et al.. Opioid prescription claims among women of reproductive age \u2014 United States, 2008-2012. Morb Mortal Wkly Rep. 2015, 64:37-41.","journal-title":"Morb Mortal Wkly Rep"},{"key":"ref4","unstructured":"Opioid use and opioid use disorder in pregnancy. (2017). Accessed. March 7, 2022: https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2017\/08\/opioid-use-and-opioid-use-disorder...."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2014.147","article-title":"Developmental consequences of fetal exposure to drugs: what we know and what we still must learn","volume":"40","author":"Ross EJ","year":"2015","unstructured":"Ross EJ, Graham DL, Money KM, Stanwood GD. Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Neuropsychopharmacology. 2015, 40:61-87. 10.1038\/npp.2014.147","journal-title":"Neuropsychopharmacology"},{"key":"ref6","unstructured":"Centers for Disease Control and Prevention (CDC). About opioid use during pregnancy. (2020). Accessed: January 4, 2021: https:\/\/www.cdc.gov\/pregnancy\/opioids\/basics.html."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0b013e31827feeb9","article-title":"Overview and epidemiology of substance abuse in pregnancy","volume":"56","author":"Wendell AD","year":"2013","unstructured":"Wendell AD. Overview and epidemiology of substance abuse in pregnancy. Clin Obstet Gynecol. 2013, 56:91-6. 10.1097\/GRF.0b013e31827feeb9","journal-title":"Clin Obstet Gynecol"},{"key":"ref8","unstructured":"SAMHSA. The national survey on drug use and health: 2018. (2018). Accessed: January 6, 2021: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/cbhsq-reports\/Assistant-Secretary-nsduh2018_presentation.pdf."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/906723","article-title":"Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States","volume":"2014","author":"Whiteman VE","year":"2014","unstructured":"Whiteman VE, Salemi JL, Mogos MF, Cain MA, Aliyu MH, Salihu HM. Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States. J Pregnancy. 2014, 2014:906723. 10.1155\/2014\/906723","journal-title":"J Pregnancy"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2017.07.023","article-title":"Opioid drug use and acute cardiac events among pregnant women in the United States","volume":"131","author":"Salihu HM","year":"2018","unstructured":"Salihu HM, Salemi JL, Aggarwal A, Steele BF, Pepper RC, Mogos MF, Aliyu MH. Opioid drug use and acute cardiac events among pregnant women in the United States. Am J Med. 2018, 131:64-71.e1. 10.1016\/j.amjmed.2017.07.023","journal-title":"Am J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2015.36","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012","volume":"35","author":"Patrick SW","year":"2015","unstructured":"Patrick SW, Davis MM, Lehmann CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015, 35:650-5. 10.1038\/jp.2015.36","journal-title":"J Perinatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7326\/L17-0067","article-title":"Marijuana use during stages of pregnancy in the United States","volume":"166","author":"Volkow ND","year":"2017","unstructured":"Volkow ND, Han B, Compton WM, Blanco C. Marijuana use during stages of pregnancy in the United States. Ann Intern Med. 2017, 166:763-4. 10.7326\/L17-0067","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.8734","article-title":"Association between self-reported prenatal cannabis use and maternal, perinatal, and neonatal outcomes","volume":"322","author":"Corsi DJ","year":"2019","unstructured":"Corsi DJ, Walsh L, Weiss D, et al.. Association between self-reported prenatal cannabis use and maternal, perinatal, and neonatal outcomes. JAMA. 2019, 322:145-52. 10.1001\/jama.2019.8734","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-015-0529-9","article-title":"Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes","volume":"19","author":"Mark K","year":"2016","unstructured":"Mark K, Desai A, Terplan M. Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes. Arch Womens Ment Health. 2016, 19:105-11. 10.1007\/s00737-015-0529-9","journal-title":"Arch Womens Ment Health"},{"key":"ref15","unstructured":"Results from the 2012 national survey on drug use and health. summary of national findings. (2013). Accessed: January 6, 2021: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUHresults2012\/NSDUHresults2012.pdf."},{"key":"ref16","unstructured":"Substance use in pregnant women underestimated. (2020). Accessed. January 6, 2021: https:\/\/www.medscape.com\/viewarticle\/930053."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/apa.13416","article-title":"Maternal drug or alcohol abuse is associated with decreased head size from\u00a0mid-pregnancy to childhood","volume":"105","author":"Lehikoinen A","year":"2016","unstructured":"Lehikoinen A, Ord\u00e9n MR, Heinonen S, Voutilainen R. Maternal drug or alcohol abuse is associated with decreased head size from\u00a0mid-pregnancy to childhood. Acta Paediatr. 2016, 105:817-22. 10.1111\/apa.13416","journal-title":"Acta Paediatr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200108023450507","article-title":"Cardiovascular complications of cocaine use","volume":"345","author":"Lange RA","year":"2001","unstructured":"Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med. 2001, 345:351-8. 10.1056\/NEJM200108023450507","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11311","article-title":"Inpatient opioid use disorder and social determinants of health: a nationwide analysis of the national inpatient sample (2012-2014 and 2016-2017)","volume":"12","author":"Sulley S","year":"2020","unstructured":"Sulley S, Ndanga M. Inpatient opioid use disorder and social determinants of health: a nationwide analysis of the national inpatient sample (2012-2014 and 2016-2017). Cureus. 2020, 12:e11311. 10.7759\/cureus.11311","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-5-21","article-title":"Maternal substance use and integrated treatment programs for women with substance abuse issues and their children: a meta-analysis","volume":"5","author":"Milligan K","year":"2010","unstructured":"Milligan K, Niccols A, Sword W, Thabane L, Henderson J, Smith A, Liu J. Maternal substance use and integrated treatment programs for women with substance abuse issues and their children: a meta-analysis. Subst Abuse Treat Prev Policy. 2010, 5:21. 10.1186\/1747-597X-5-21","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-011-0923-5","article-title":"Barriers to receiving substance abuse treatment among rural pregnant women in Kentucky","volume":"16","author":"Jackson A","year":"2012","unstructured":"Jackson A, Shannon L. Barriers to receiving substance abuse treatment among rural pregnant women in Kentucky. Matern Child Health J. 2012, 16:1762-70. 10.1007\/s10995-011-0923-5","journal-title":"Matern Child Health J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2009.60.7.880","article-title":"Alcohol & drug abuse: what is \u201cwomen-focused\u201d treatment for substance use disorders?","volume":"60","author":"Greenfield SF M D M P H","year":"2009","unstructured":"Greenfield SF M D M P H, Grella CE Ph D. Alcohol & drug abuse: what is \u201cwomen-focused\u201d treatment for substance use disorders?. Psychiatr Serv. 2009, 60:880-2. 10.1176\/ps.2009.60.7.880","journal-title":"Psychiatr Serv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/76797-trend-analysis-of-substance-use-disorder-during-pregnancy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:14Z","timestamp":1707507794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/76797-trend-analysis-of-substance-use-disorder-during-pregnancy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,27]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.23548","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,27]]}}}